Review



anti- alk2  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Millipore anti- alk2
    Anti Alk2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/ldn193189/pm39010233-105-11-13
    Average 90 stars, based on 1 article reviews
    anti- alk2 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Produced:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Isolation:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Staining:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Software:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Expressing:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Quantitative RT-PCR:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Ex Vivo:

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.

    Article Title: TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.
    Article Snippet: Primary Abs w6.32 (Abcam) and CD45RC (Bio-rad) are produced in mice, anti- ALK2 (Sigma-Aldrich), anti- ALK3 (Invitrogen) and anti- ALK5 (Sigma-Aldrich) are produced in rabbit.



    Similar Products

    93
    Sino Biological alk2 acvr1
    Alk2 Acvr1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/ALK-2+%2F+ACVR1+Antibody%2C+Rabbit+PAb%2C+Antigen+Affinity+Purified/pm40121219-221-56-57
    Average 93 stars, based on 1 article reviews
    alk2 acvr1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-alk2 antibody
    Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, <t>ALK2,</t> Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.
    Rabbit Anti Alk2 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/pmc11345179-153-24-29
    Average 90 stars, based on 1 article reviews
    rabbit anti-alk2 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    93
    R&D Systems polyclonal anti alk2 antibody
    Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, <t>ALK2,</t> Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.
    Polyclonal Anti Alk2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/Human+Activin+RIA%2FALK-2+Antibody/us12428484-826-1-4
    Average 93 stars, based on 1 article reviews
    polyclonal anti alk2 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Creative BioMart biotinylated alk2 ecd
    Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, <t>ALK2,</t> Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.
    Biotinylated Alk2 Ecd, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/Recombinant+Human+Activin+A+Receptor%2C+Type+I/us12428484-808-29-32
    Average 93 stars, based on 1 article reviews
    biotinylated alk2 ecd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Proteintech alk2
    Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, <t>ALK2,</t> Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.
    Alk2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/ACVR1+Antibody/pm40494204-73-20-22
    Average 93 stars, based on 1 article reviews
    alk2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems alk2
    Figure 6. Receptor expressions of <t>ALK2,</t> ALK4, ALK6, ALK5, ALK7, BMPR-II in pASC. Grouped representation of the respective receptor expression in the course of osteogenic differentiation (OM +/−BMP-2). From day 19, there is a significant induction of ALK 2, ALK 6, and ALK 5 with the addition of BMP-2. BMPR-II expression in the OM group decreased in OM and tended to stay increased under BMP-2 supplementation from day 19, but was not considered significant (* p ≤0.05, ** p ≤0.01; n = 6, BMP-2 450 ng/mL).
    Alk2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/Human+Activin+RIA%2FALK-2+Antibody/pm40563862-64-31-45
    Average 93 stars, based on 1 article reviews
    alk2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Millipore anti- alk2
    Figure 6. Receptor expressions of <t>ALK2,</t> ALK4, ALK6, ALK5, ALK7, BMPR-II in pASC. Grouped representation of the respective receptor expression in the course of osteogenic differentiation (OM +/−BMP-2). From day 19, there is a significant induction of ALK 2, ALK 6, and ALK 5 with the addition of BMP-2. BMPR-II expression in the OM group decreased in OM and tended to stay increased under BMP-2 supplementation from day 19, but was not considered significant (* p ≤0.05, ** p ≤0.01; n = 6, BMP-2 450 ng/mL).
    Anti Alk2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-+alk2/ldn193189/pm39010233-105-11-13
    Average 90 stars, based on 1 article reviews
    anti- alk2 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, ALK2, Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.

    Journal: Frontiers in Pharmacology

    Article Title: BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling

    doi: 10.3389/fphar.2024.1426121

    Figure Lengend Snippet: Graphical representation of the experimental design. Experiment 1: Changes in pain sensitization and expressions of BMP10, ALK2, Smad1/5/8, phosphorylated Smad1/5/8, and GFAP after SNI in mice. Experiment 2: The effects of BMP10 siRNA on SNI-induced pain hypersensitivity and astrocytic activation. Experiment 3: The involvements of ALK2 in BMP10-induced pain hypersensitivity and astrocytic activation. Experiment 4: The effects of Smad1 siRNA on BMP10-induced pain hypersensitivity and astrocytic activation.

    Article Snippet: The membranes were incubated with appropriate antibodies, including mouse anti-GFAP antibody (1:1,000, ab279289, Abcam), mouse anti-BMP10 antibody (1:1,000, 462732, Novus Biologicals, CO, United States), rabbit anti-ALK2 antibody (1:100, PA5-114818, Thermo Fisher Scientific, MA, United States), rabbit anti-phospho-Smad1/5/8 (1:1,000, AB3848-I, Sigma Aldrich, Germany), rabbit anti-Smad1/5/8 (1:1,000, NB100-56656, Novus Biologicals, CO, United States) and mouse anti-β-actin (1:1,000, AF2815, Beyotime Biotechnology , Shanghai, China) overnight at 4°C.

    Techniques: Activation Assay

    Expression levels of ALK2, Samd1/5/8, and p-Smad1/5/8 in mouse ipsilateral spinal dorsal horn after SNI. (A–C) Western blot analysis showed the expression levels of ALK2, Samd1/5/8, and p-Smad1/5/8 in the ipsilateral (above) and contralateral (below) spinal dorsal horn of sham and SNI mice; (D) Double immunofluorescence staining showed the coexpression of ALK2 (red) with GFAP, Iba-1 and NeuN (green) in the ipsilateral spinal dorsal horn of SNI mice on postoperative Day 14 (scale bar = 50 μm/25 μm). Data are presented as mean and SEM; sham mice versus SNI mice on postoperative Days 7 and 14, *** p < 0.001 (n = 6).

    Journal: Frontiers in Pharmacology

    Article Title: BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling

    doi: 10.3389/fphar.2024.1426121

    Figure Lengend Snippet: Expression levels of ALK2, Samd1/5/8, and p-Smad1/5/8 in mouse ipsilateral spinal dorsal horn after SNI. (A–C) Western blot analysis showed the expression levels of ALK2, Samd1/5/8, and p-Smad1/5/8 in the ipsilateral (above) and contralateral (below) spinal dorsal horn of sham and SNI mice; (D) Double immunofluorescence staining showed the coexpression of ALK2 (red) with GFAP, Iba-1 and NeuN (green) in the ipsilateral spinal dorsal horn of SNI mice on postoperative Day 14 (scale bar = 50 μm/25 μm). Data are presented as mean and SEM; sham mice versus SNI mice on postoperative Days 7 and 14, *** p < 0.001 (n = 6).

    Article Snippet: The membranes were incubated with appropriate antibodies, including mouse anti-GFAP antibody (1:1,000, ab279289, Abcam), mouse anti-BMP10 antibody (1:1,000, 462732, Novus Biologicals, CO, United States), rabbit anti-ALK2 antibody (1:100, PA5-114818, Thermo Fisher Scientific, MA, United States), rabbit anti-phospho-Smad1/5/8 (1:1,000, AB3848-I, Sigma Aldrich, Germany), rabbit anti-Smad1/5/8 (1:1,000, NB100-56656, Novus Biologicals, CO, United States) and mouse anti-β-actin (1:1,000, AF2815, Beyotime Biotechnology , Shanghai, China) overnight at 4°C.

    Techniques: Expressing, Western Blot, Double Immunofluorescence Staining

    ALK2 was involved in BMP10-induced pain hypersensitivity and astrocytic activation. (A, B) The time course of PWT and TWL in normal mice after intrathecal delivery of BMP10 peptide and reagents; Data are presented as mean and SEM, Vehicle group versus BMP10 group * p < 0.05, ** p < 0.01, *** p < 0.001; BMP10+ALK2-IN-2 group versus BMP group # p < 0.05, ## p < 0.01, ### p < 0.001 (n = 12); (C) Representative movement traces in OFT tests of mice after intrathecal delivery of BMP10 peptide and reagents; (D–F) Time in center zone, average speed and total distance of mice in open field after intrathecal delivery of BMP10 peptide and reagents; (G, H) immunofluorescence staining showed the expression of GFAP in the spinal dorsal horn after intrathecal delivery of BMP10 peptide and reagents (scale bar = 200/50 μm); (I) Western blot showed the expression of GFAP in the spinal cord after intrathecal delivery of BMP10 peptide and reagents; Data are presented as mean and SEM, Vehicle group versus BMP10 group * p < 0.05, ** p < 0.01, *** p < 0.001; BMP10+ ALK2-IN-2 group versus BMP group # p < 0.05, ## p < 0.01, ### p < 0.001 (n = 6).

    Journal: Frontiers in Pharmacology

    Article Title: BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling

    doi: 10.3389/fphar.2024.1426121

    Figure Lengend Snippet: ALK2 was involved in BMP10-induced pain hypersensitivity and astrocytic activation. (A, B) The time course of PWT and TWL in normal mice after intrathecal delivery of BMP10 peptide and reagents; Data are presented as mean and SEM, Vehicle group versus BMP10 group * p < 0.05, ** p < 0.01, *** p < 0.001; BMP10+ALK2-IN-2 group versus BMP group # p < 0.05, ## p < 0.01, ### p < 0.001 (n = 12); (C) Representative movement traces in OFT tests of mice after intrathecal delivery of BMP10 peptide and reagents; (D–F) Time in center zone, average speed and total distance of mice in open field after intrathecal delivery of BMP10 peptide and reagents; (G, H) immunofluorescence staining showed the expression of GFAP in the spinal dorsal horn after intrathecal delivery of BMP10 peptide and reagents (scale bar = 200/50 μm); (I) Western blot showed the expression of GFAP in the spinal cord after intrathecal delivery of BMP10 peptide and reagents; Data are presented as mean and SEM, Vehicle group versus BMP10 group * p < 0.05, ** p < 0.01, *** p < 0.001; BMP10+ ALK2-IN-2 group versus BMP group # p < 0.05, ## p < 0.01, ### p < 0.001 (n = 6).

    Article Snippet: The membranes were incubated with appropriate antibodies, including mouse anti-GFAP antibody (1:1,000, ab279289, Abcam), mouse anti-BMP10 antibody (1:1,000, 462732, Novus Biologicals, CO, United States), rabbit anti-ALK2 antibody (1:100, PA5-114818, Thermo Fisher Scientific, MA, United States), rabbit anti-phospho-Smad1/5/8 (1:1,000, AB3848-I, Sigma Aldrich, Germany), rabbit anti-Smad1/5/8 (1:1,000, NB100-56656, Novus Biologicals, CO, United States) and mouse anti-β-actin (1:1,000, AF2815, Beyotime Biotechnology , Shanghai, China) overnight at 4°C.

    Techniques: Activation Assay, Immunofluorescence, Staining, Expressing, Western Blot

    Figure 6. Receptor expressions of ALK2, ALK4, ALK6, ALK5, ALK7, BMPR-II in pASC. Grouped representation of the respective receptor expression in the course of osteogenic differentiation (OM +/−BMP-2). From day 19, there is a significant induction of ALK 2, ALK 6, and ALK 5 with the addition of BMP-2. BMPR-II expression in the OM group decreased in OM and tended to stay increased under BMP-2 supplementation from day 19, but was not considered significant (* p ≤0.05, ** p ≤0.01; n = 6, BMP-2 450 ng/mL).

    Journal: Biology

    Article Title: BMP-2-Driven Osteogenesis: A Comparative Analysis of Porcine BMSCs and ASCs and the Role of TGF-β and FGF Signaling.

    doi: 10.3390/biology14060610

    Figure Lengend Snippet: Figure 6. Receptor expressions of ALK2, ALK4, ALK6, ALK5, ALK7, BMPR-II in pASC. Grouped representation of the respective receptor expression in the course of osteogenic differentiation (OM +/−BMP-2). From day 19, there is a significant induction of ALK 2, ALK 6, and ALK 5 with the addition of BMP-2. BMPR-II expression in the OM group decreased in OM and tended to stay increased under BMP-2 supplementation from day 19, but was not considered significant (* p ≤0.05, ** p ≤0.01; n = 6, BMP-2 450 ng/mL).

    Article Snippet: The respective conjugated antibodies were used for the expressions of ALK3 (Cat. No.: AF436), ALK 5 (Cat. No.: FAB5871), ALK6 (Cat. No.: FAB5051A), TGF-β2-RII (Cat. No.: FAB532P), ALK7 (Cat. No.: FAB77491A), ALK2 (Cat. No.: AF637), ALK4 (Cat. No.: MAB2221), and BMPR-II (Cat. No.: AF811) (by R&D Systems, Minneapolis, MN, USA), and the pASCs and pBMSCs were compared for their expressions of the specific surface antigens CD45 (Cat. No.: MCA1568GA, BioRad, Hercules, CA, USA), HLA-DR (human leukocyte antigen–antigen D-related surface molecule) (Cat. No.: MCA2314F, Bio-Rad, Hercules, CA, USA), CD29 (Cat. No.: 561,496, BD Pharmingen, Franklin Lakes, NJ, USA), CD79alpha (Bio-Rad, Cat. No.: MCA2538GA), CD14 (Cat. No.: MCA1568GA, Bio-Rad, Hercules, CA, USA), CD31 (Cat. No.: AF3387, R&D Systems, Minneapolis, MN, USA), CD105 (Cat. No.: NB110-58718APC, Novus Biologicals, Minneapolis, MN, USA), CD26 (, Cat. No.: NB600-552APC, Novus Biologicals, Minneapolis, MN, USA), CD73 (, Cat. No.: AF4488, R&D Systems, Minneapolis, MN, USA), CD90 (Cat. No.: 559,869, BD Pharmingen, Franklin Lakes, NJ, USA), CD34 (Cat. No.: 81289, abcam, Cambridge, UK), and CD44 (Cat. No.: 5531, BD Pharmingen, Franklin Lakes, NJ, USA).

    Techniques: Expressing